"A Phase III, Randomized Clinical Trial of Standard Adjuvant Endocrine Therapy +/- Chemotherapy in Patients with 1-3 Positive Nodes, Hormone Receptor-Positive and HER-2 Negative Breast Cancer with Recurrence Score (RS) of 25 or Less. RxPONDER: A Clinical Trial RX for Positive Node, Endocrine Responsive Breast Cancer"

This Study is
No Longer Enrolling

Details
Age

Adult

Type of Study

Treatment

Locations

Greeley Campus
Harmony Campus
Medical Center of the Rockies
Poudre Valley Hospital

Study ID

Protocol Number: UCH11-1079

More information available at ClinicalTrials.gov: NCT01272037

Not finding the right Study for you? Join ResearchMatch, a nation-wide registry connecting volunteers and researchers